Toward A Pill To Enable Celiac Patients To Eat Foods Containing Gluten
Justin Siegel, Ingrid Swanson Pultz and colleagues explain that celiac disease is an autoimmune disorder in which the gluten in wheat, rye or barley products causes inflammation in the digestive tract. Enzymes in the stomach break down gluten into smaller pieces, called peptides. For most people, these peptides are harmless. But for the 2 million-3 million Americans with celiac disease, the peptides trigger an autoimmune response and painful symptoms. Currently, the only treatment is a gluten-free diet. However, the scientists reasoned that if an enzyme could further break down the offending peptides in the stomach, celiac patients might be able to eat gluten-containing foods.
They describe discovery of a naturally occurring enzyme that has some of the ideal properties for doing so. The scientists modified the enzyme in the laboratory so that it would meet all the necessary criteria. The new enzyme (called KumaMax) broke down more than 95 percent of a gluten peptide implicated in celiac disease in acidic conditions like those in the stomach. "These combined properties make the engineered [enzyme] a promising candidate as an oral therapeutic for celiac disease," say the researchers.
The authors acknowledge funding from the Howard Hughes Medical Institute and the Defense Advanced Research Projects Agency
"Computational Design of an α-Gliadin Peptidase”,
Sydney R. Gordon et al.
Journal of the American Chemical Society. 2012, 134 (50), pp 20513-20520 DOI: 10.1021/ja3094795
Please use one of the following formats to cite this article in your essay, paper or report:
American Chemical Society. "Toward A Pill To Enable Celiac Patients To Eat Foods Containing Gluten." Medical News Today. MediLexicon, Intl., 1 Feb. 2013. Web.
28 May. 2017. <http://www.medicalnewstoday.com/releases/255705.php>
American Chemical Society. (2013, February 1). "Toward A Pill To Enable Celiac Patients To Eat Foods Containing Gluten." Medical News Today. Retrieved from
Please note: If no author information is provided, the source is cited instead.
Contact our news editors
For any corrections of factual information, or to contact our editorial team, please see our contact page.
Copyright Medical News Today: Excluding email/sharing services explicitly offered on this website, material published on Medical News Today may not be reproduced, or distributed without the prior written permission of Medilexicon International Ltd. Please contact us for further details.